The means by which coxsackievirus type A9 (CA9) is inactivated by proteolytic enzymes was investigated. After reaction of '4C-leucine-labeled CA9 with Pronase, free leucine was liberated as measured by radiochromatography. Treatment of 14C-leucine-labeled CA9 with trypsin or proteolytic filtrates of Pseudomonas aeruginosa caused the release of a variety of labeled substances. The extent of viral ribonucleic acid (RNA) release after exposure of CA9 to Pronase was determined by RNA infectivity tests or trichloroacetic acid solubility tests. Infective viral RNA was found not to be consistently released by reaction of CA9 with Pronase, but further treatment with 1% sodium dodecyl sulfate at pH 7.0 promoted viral RNA release. Sodium dodecyl sulfate treatment of CA9 that had not been reacted with Pronase did not inactivate virus or cause viral RNA release. Reaction of Pronase with 32P-labeled CA9 resulted in the liberation of virus components soluble in cold trichloroacetic acid, whereas untreated CA9 or CA9 reacted with ribonuclease were precipitated by cold trichloroacetic acid. These results demonstrate that the primary means by which protease-sensitive enteroviruses are inactivated is by degradation of the virus capsid, with subsequent release of viral RNA.
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Because enteroviruses have a protein capsid and no envelope structures, they should be susceptible to at least some proteolytic enzymes. The evidence, however, has indicated that these viruses are highly resistant to protease action. In fact, proteases have been used to purify poliovirus from contaminating proteins (1) . Also, Keller (8) found in his studies on enzyme reactivation of poliovirus neutralized by antibody that pepsinor papain-treated virus preparations actually showed a 20 to 40% increase in infectivity. In addition, the mode of enterovirus transmission suggests that enteroviruses survive the proteases of the intestinal tract. There are some rel)orts, though, which indicate that proteases and other enzymes may alter the infectivity of a few of the enteroviruses. Lysozyme has been found to decrease the infectivity of poliovirus type 1 and several echoviruses (9) , and trypsin has been reported to cause infectivity losses when reacted with coxsackievirus type A9 (CA9; reference 12). In a previous study (4), we determined the susceptibility of selected eilterovirus types to trypsin, to several proteolytic enzymes of microbial origin, and to cultures of proteolytic bacteria. CA9 was found to be inactivated by trypsin by most of the proteolytic bacteria and microbial proteases tried. Coxsackieviruses types A7 and B2 were partially inactivated by Pronase but not by trypsin. Polioviruses types 1 through 3 and coxsackieviruses types Bi and B3 were resistant to all proteases tested. In this report, we describe an extension of our prior findings to the determination of the manner of CA9 inactivation by proteases. MATERIALS AND METHODS Virus and tissue cultures. CA9 strain Bozek was obtained from the ATCC. Tissue cultures used for the propagation and titration of this virus were primary rhesus (Macaca mulatta) monkey kidney (PMK) monolayers. The procedures for the preparation of these cultures and their use in virus titration in our laboratory have been described (3).
Enzymes. Trypsin (beef pancreas, 2 X crystalline) and ribonuclease (beef pancreas, 5 X crystalline) were obtained from Nutritional Biochemicals, Cleveland. Nuclease-free Pronase (Streptomyces griseus), B grade, was from Calbiochem, Los Angeles. Unless stated otherwise, these enzymes were dissolved and diluted in phosphatebuffered saline (PBS), pH 7.2, as they were required.
Radioactive virus preparation. Preparation of 32P-labeled virus was based on the method of Giron (6) . PMK tissue cultures were maintained 514HER{RMANN AND CLIVERIT in phosphate-free miniimlal essenitial medium (MEM) plus 0.17% NaHCO3 (PF-MEM) for 6 h at 37 C. At that time, PF-MEM plus 5 ,ug of actinomycin D per ml (Nutritional Biochemicals, Cleveland) were added, and the cultures were incubated for 1 h at 37 C. The medium was poured off, and 0.5 ml of virus suspended in PF-MEM was inoculated at a concentration of 10 plaqueforming units (PFU) per cell. After 30 min of adsorption at 37 C, the inoculum was poured off and the cultures were rinsed twice with PF-MEM. Five milliliters of PF-MEM containing 50 ,Ci of carrier-free 32P-labeled NaH2PO4 per ml (International Chemical and Nuclear Corp., Irvine, Calif.) was added. The cultures were incubated at 37 C for 18 h. At that time, virus was harvested by three freeze-thaw cycles and cell debris was removed by centrifugation at 2,000 X g. Labeled virus was concentrated approximately fivefold by dialysis against a 70% solution of polyethylene glycol (Carbowax 20,000) in distilled water. The concentrated virus was purified by passage through a diethylaminoethyl (DEAE)-Sephadex A-25 (Pharmacia, Uppsala, Sweden) column by using 0.06 M phosphate buffer, pH 7.5, as eluent. The preparation of the Sephadex column was as described by Giron and Heliman (7) .
For preparation of '4C-leucine-labeled virus,
PMK tissue cultures were starved of leucine for 18 h by incubation at 37 C with Earle balanced salt solution (EBSS). The cultures were inoculated with virus suspended in EBSS at a concentration of 10 PFU per cell, adsorbed 20 min at room temperature, and rinsed twice with EBSS. Uniformly labeled 14C-leucine (specific activity 240 mCi/mM) (International Chemical and Nuclear Corp., Irvine, Calif.) in EBSS (10,Ci/ml) was added, and the cultures were incubated for 18 h at 37 C. The cultures were freeze-thawed three times, and the harvested virus was centrifuged at 2,000 X g to remove cell debris. The supernatant fluids were concentrated and puiified in the same manner as was done above for 32P-labeled virus.
For both preparations, the effluent column fractions in which peak counts per min and peak virus PFU coincided were the fractions used as labeled virus. Virus labeled with 14C-leucine yielded from 2 X 101 to 3 X 103 PFU per counts per min, and 32P-labeled virus yielded 1.5 X 103 to 5 X 103 PFU per counts per min. All counting of radioactive samples was done with a gas-flow, Mylar window counter (Baird Atomic, Inc., Cambridge, Mass.).
The degree of virus-label specificity was determined by the percentage of virus adsorption to cellulose nitrate filter membranes. By this method (submitted for publication) we determined that approximately 95% or more of the total radioactivity in any given sample was virus associated.
Proteolytic bacterial culture filtrates. A strain of P. aeruginosa, obtained from J. M. Goepfert, Univ. of Wisconsin, Madison, was grown for 8 days at 37 C in Trypticase soy broth (BBL).
The culture was freeze-thawed three times and cenltrifuged for 30 miii at 15,000 rpm (24,800 X g max) in a Spinco model L ultracentrifuge no. 50.1 rotor. The supernatant fluid was filtered through Gelman 1,200and 200-nm filter membranes. The Gelman 200-nm filtrate was fractionated by pressure filtration through size-exclusion Diaflo membranes (Amicon Corp., Lexington, Mass.) types XM100 and XM50.
The XM50 filtrate, according to manufacturer's specifications, contained products with molecular weights of <50,000. This filtrate retained proteolytic activity, as measured by milk clearance (10) .
Assay for viral RNA infectivity. The method of Pagano et al. (13) was used. Duplicate PMK tissue cultures were rinsed once with 5 ml of PBS. These were inoculated with either 0.5 ml of riboinucleic acid (RNA) diluted in PBS, or with 0.5 ml of RNA preparations premixed 1:1 with 1 mg of DEAE-dextran per ml. After adsorption for 20 min at room temperature, the cultures were washed once with 5 ml of PBS and 5 ml of overlay was added. The overlay medium consisted of MEM plus 2% fetal calf serum, 1% Noble agar, 0.17% NaHCO3, 15 ug of neutral red per ml, penicillin (100 U/ml), and dihydrostreptomycin (100 /Ag/ml). The cultures were incubated at 37 C, and plaques were counted after 3 to 5 days.
Assay for acid solubility of viral RNA. The procedure of Mandel (11) was adapted for our use as follows. One milliliter each of treated and nontreated samples of 32P-labeled CA9 in 0.1 M tris (hydroxymethyl)aminomethane (Tris) buffer, pH 7.5, was chilled for 15 min in an ice bath. To each, 0.2 ml of a cold solution of bovine serum albumin (7 mg/ml) and 0.3 ml of cold trichloroacetic acid, 50% solution, were added and chilled in an ice bath for 1 h. The reaction mixtures were centrifuged for 15 min at 2,000 X g. The supernatant fluids were collected and the precipitates were dissolved in 2.5 N NaOH. Samples of each were taken for radioactivity assay.
Chromatography and chromatogram scanning. Treated radioactive virus samples and controls (0.1 ml each) were spotted on Whatman no. 1 chromatography paper. One-dimensional ascending chromatography was then performed by using a mixture of secondary butanol-formic acid-water (140:20:40) as the solvent system. Scanning of radioactive strip chromatograms was done with a Vanguard model 880 low-background Autoscanner (Vanguard Instrument Co., LaGrange, Ill.). The scanner was adjusted to record a maximum count of 3,000 counts/min. RESULTS
Release of viral RNA. Attempts to determine if viral RNA was being released by protease treatment were made by RNA infectivity and trichloroacetic acid solubility tests. For infectivity determinations, 0.9 ml of stock CA9 diluted 1 :10 in PBS was treated with 0.1 ml of nucleasefree Pronase (10 mg/ml) for 1 h at 37 C. The Table 1 show that the samples treated with DEAEdextran (RNA assay) showed a significant increase in PFU/ml only in samples treated with both Pronase and SDS, and that this increase was abolished by RNase treatment. Neither SDS nor RNase treatment caused any reduction in the PFU per milliliter of virus that was not treated with Pronase. Pronase that had been reacted with the inhibitor phenylmethyl sulfonylfluoride (14) , obtained from Mann Research Lab., New York, caused only limited inactivation of CA9.
Because the efficiency of RNA plaque formation is usually low ( < 1%), the majority of viral RNA can be released without detection by infectivity tests. Also, preliminary results had shown that treatment of CA9 with Pronase for longer periods of time did not increase RNA infectivity, although there was greater CA9 inactivation. For these reasons, RNA release was determined by the use of trichloroacetic acid solubility tests, as follows. 32P-labeled CA9 (0.1 ml) was added to 0.8 ml of Tris buffer (pH 7.5), 0.1 M. One-tenth milliliter of nuclease-free Pronase (10 mg/ml) was added. After incubation for 2 h at 37 C, the mixture was chilled and treated as described in Methods. The control for the possible presence of nonvirallabeled RNA in labeled virus preparations was treatment of intact '2P-labeled CA9 with RNase (1 mg/ml) for 30 min at room temperature. The results ( Table 2) show that Pronase caused the release of components of CA9 soluble in cold trichloroacetic acid, which did not occur with samples not treated with Pronase or with RNasetreated virus.
Virus degradation. Having shown by trichloroacetic acid solubility tests that RNA was being released from CA9 by Pronase treatment, the degree of coat protein (capsid) breakdown was determined by the use of 14C-leucine-labeled virus. Initial determinations were done by treating 0.1 ml of '4C-leucine-labeled CA9 with 0.9 ml of Pronase (1 mg/ml). The virus-enzyme mixtures were reacted for 1 h at 37 C and diluted in 5 ml of PBS. These samples and controls (labeled CA9 in PBS plus 5% calf serum) were filtered through Millipore VF membranes (nominal pore size Inow given at 25 nm), and the filtrates were compared for counts per minute. The results given in Table 3 show that 88 % of the radioactivity from the Pronase-treated virus passed the filters, and only 5% of the radioactivity from the untreated virus passed to the filtrate.
The degree of capsid breakdown was determined by radiochromatographic methods. Intact '4C-leucine-labeled CA9 was treated with Pronase (1 mg/ml) under conditions known to cause complete digestion of other proteiins (18 h at 37 C), or with trypsin (1 mg/ml), or with an XM50 P. aeruginosa fraction (0.2 ml of virus plus 1.8 ml of fraction) for the same time period. Test samples and controls (untreated virus and free leucine) were spotted oIn chromatography paper and treated as described. Figure 1 shows the results obtained by scanning the chromatograms. Untreated CA9 did not migrate significantly from the origin, which is another indication of the purity of the labeled virus prel)aration. A comparison of the migration lpatterns obtained with a stock solution of 14C- 
DISCUSSION
In most of the reports concerned with enterovirus degradation, chemical treatments have been used. The use of proteases in degradation studies was not considered, because enteroviruses were assumed to be protease resistant, based on results obtained with poliovirus as the model agent. Our previous findings (4) indicated that this was not a valid assumption. The results of our tests with poliovirus susceptibility to a wide variety of proteolytic enzymes showed that this virus was completely resistant, which was in agreement with previous reports in the literature. However, in contrast to the results found with poliovirus, we showed that at least two coxsackie A viruses, A7 and A9, and one B type, B2, were sensitive to some proteases.
The data presented in this paper demonstrate that protease sensitivity of the model enterovirus used, CA9, is due to digestion of the virion capsid, based on two lines of evidence: (i) the release of trichloroacetic acid-soluble radioactive components after treatment of 82P-labeled CA9 with Pronase, and (ii) the release of 14C-labeled components from "4C-leucine-labeled CA9 after treatment with Pronase and other proteases. The initial site of protease action against CA9 was not investigated, but the results obtained with Pronase-treated CA9 suggest that the first step in degradation of this virus is similar to the virion dissociation that results after enteroviruses are heated (2) or eluted from host cells (5, 11) . Elution of coxsackievirus type B3 from host cells causes the release of the low-molecular-weight capsid protein VP4, which occurs without concomitant release of viral RNA (5) . This is similar to our finding that Pronase-inactivated CA9 does not release infective RNA when the enzyme-virus reaction time is of short duration (1 h at 37 C). Longer reaction times with Pronase, though, resulted in release of trichloroacetic acid-soluble 32P-labeled components, with subsequent complete digestion of the capsid.
